[Aria Pharmaceuticals in Life Science Leader] Andrew Radin orchestrates his AI discovery platform’s pivot to R&D with a harmonious name change and eyes on the clinic

Andrew Radin was a straight A student. So when he stopped turning in assignments in Nigam Shah’s class at Stanford University, the professor knew something was up.

Read more here.